Abaxis (Abaxis) Days Payable : 37.21 (As of Mar. 2018)

View and export this data going back to 1992. Start your Free Trial

What is Abaxis Days Payable?

Abaxis's average Accounts Payable for the three months ended in Mar. 2018 was $12.5 Mil. Abaxis's Cost of Goods Sold for the three months ended in Mar. 2018 was $30.6 Mil. Hence, Abaxis's Days Payable for the three months ended in Mar. 2018 was 37.21.

The historical rank and industry rank for Abaxis's Days Payable or its related term are showing as below:

ABAX's Days Payable is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 68.79
* Ranked among companies with meaningful Days Payable only.

Abaxis's Days Payable increased from Mar. 2017 (28.83) to Mar. 2018 (37.21). It may suggest that Abaxis delayed paying its suppliers.

Abaxis Days Payable Historical Data

The historical data trend for Abaxis's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abaxis Days Payable Chart

Abaxis Annual Data

Trend

Mar09

Mar10

Mar11

Mar12

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Days Payable

Get a 7-Day Free Trial

31.90

24.96

27.80

26.66

31.69

Abaxis Quarterly Data
	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18
Days Payable	Get a 7-Day Free Trial															28.83	30.83	31.89	35.78	37.21

Competitive Comparison of Abaxis's Days Payable

For the Diagnostics & Research subindustry, Abaxis's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abaxis's Days Payable Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Abaxis's Days Payable distribution charts can be found below:

* The bar in red indicates where Abaxis's Days Payable falls into.

Abaxis Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Abaxis's Days Payable for the fiscal year that ended in Mar. 2018 is calculated as

	Days Payable (A: Mar. 2018 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Mar. 2017 )	+	Accounts Payable (A: Mar. 2018 ))	/	count )	/	Cost of Goods Sold (A: Mar. 2018 )	*	Days in Period
=	( (7.517	+	11.775)	/	2 )	/	111.091	*	365
=	9.646					/	111.091	*	365
=	31.69

Abaxis's Days Payable for the quarter that ended in Mar. 2018 is calculated as:

	Days Payable (Q: Mar. 2018 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2017 )	+	Accounts Payable (Q: Mar. 2018 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2018 )	*	Days in Period
=	( (13.17	+	11.775)	/	2 )	/	30.59	*	365 / 4
=	12.4725					/	30.59	*	365 / 4
=	37.21

Abaxis Days Payable Related Terms

Thank you for viewing the detailed overview of Abaxis's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Abaxis (Abaxis) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Abaxis Inc (NAS:ABAX) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.abaxis.com

Abaxis Inc manufactures point-of-care blood analysis instruments and consumables for medical and veterinary care providers. The medical segment sells Piccolo Chemistry Analyzers, which can provide results about a blood sample in 12 minutes, and related reagents to physicians, hospitals, pharmacies, and other healthcare providers. The veterinary segment generates the majority of the firm's total revenue and sells products to animal hospitals, veterinary clinics, and private research laboratories. Products in this segment include the VetScan VS2 chemistry analyzer, animal-specific reagents, and rapid tests for canine and feline diseases. The vast majority of the firm's revenue comes from North America and Europe.

Executives

Richard Bastiani	director	C/O ABAXIS INC, 3240 WHIPPLE RD, UNION CITY CA 94587
Taylor Dean Ross Jr	officer: CFO and VP of Finance	C/O ABAXIS INC, 3240 WHIPPLE ROAD, UNION CITY CA 94587
Clinton Severson	director, officer: CEO & Board Chairman	C/O ABAXIS INC, 3240 WHIPPLE ROAD, UNION CITY CA 94587
Michael D Casey	director	ALLOS THERAPEUTICS, INC., 11080 CIRCLEPOINT ROAD, SUITE 200, WESTMINSTER CO 80020